Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Evoke Pharma (EVOK) Non-cash Items (2020 - 2024)

Historic Non-cash Items for Evoke Pharma (EVOK) over the last 5 years, with Q4 2024 value amounting to $5442.0.

  • Evoke Pharma's Non-cash Items fell 9869.99% to $5442.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $5442.0, marking a year-over-year decrease of 9869.99%. This contributed to the annual value of $5442.0 for FY2024, which is 9869.99% down from last year.
  • As of Q4 2024, Evoke Pharma's Non-cash Items stood at $5442.0, which was down 9869.99% from $418591.0 recorded in Q4 2023.
  • Evoke Pharma's Non-cash Items' 5-year high stood at $5.1 million during Q4 2020, with a 5-year trough of $5442.0 in Q4 2024.
  • Moreover, its 5-year median value for Non-cash Items was $418591.0 (2023), whereas its average is $1.6 million.
  • Per our database at Business Quant, Evoke Pharma's Non-cash Items crashed by 9963.41% in 2022 and then soared by 433422.67% in 2023.
  • Evoke Pharma's Non-cash Items (Quarter) stood at $5.1 million in 2020, then plummeted by 49.75% to $2.6 million in 2021, then crashed by 99.63% to $9440.0 in 2022, then surged by 4334.23% to $418591.0 in 2023, then tumbled by 98.7% to $5442.0 in 2024.
  • Its Non-cash Items stands at $5442.0 for Q4 2024, versus $418591.0 for Q4 2023 and $9440.0 for Q4 2022.